13.0(top 1%)
impact factor
2.9K(top 10%)
132.9K(top 5%)
169(top 2%)
13.4(top 1%)
extended IF
all documents
doc citations
253(top 2%)

Top Articles

1Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology20205,308
2Amyloid-β and TauJAMA Neurology20141,416
3Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic DrugsJAMA Neurology2018910
4Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019JAMA Neurology2020748
5Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer DiseaseJAMA Neurology2017664
6Inflammation and Neuroprotection in Traumatic Brain InjuryJAMA Neurology2015625
7The Parkinson Pandemic—A Call to ActionJAMA Neurology2018584
8Sleep Quality and Preclinical Alzheimer DiseaseJAMA Neurology2013570
9Seizures and Epileptiform Activity in the Early Stages of Alzheimer DiseaseJAMA Neurology2013566
10The Preclinical Alzheimer Cognitive CompositeJAMA Neurology2014548
11Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein AntibodiesJAMA Neurology2014519
12Association of Amyloid and Tau With Cognition in Preclinical Alzheimer DiseaseJAMA Neurology2019512
13Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With InfluenzaJAMA Neurology2020506
14Association of Proton Pump Inhibitors With Risk of DementiaJAMA Neurology2016459
15New Clinical Subtypes of Parkinson Disease and Their Longitudinal ProgressionJAMA Neurology2015456
16Current Concepts in Diagnosis and Treatment of Functional Neurological DisordersJAMA Neurology2018455
17Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in NeurologyJAMA Neurology2019455
18Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer DiseaseJAMA Neurology2017454
19Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the PopulationJAMA Neurology2019452
20Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer DiseaseJAMA Neurology2019436
21History, Applications, and Mechanisms of Deep Brain StimulationJAMA Neurology2013420
22Self-reported Sleep and β-Amyloid Deposition in Community-Dwelling Older AdultsJAMA Neurology2013414
23Evaluation of Galcanezumab for the Prevention of Episodic MigraineJAMA Neurology2018413
24Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) CohortJAMA Neurology2017404
25Vitamin D as an Early Predictor of Multiple Sclerosis Activity and ProgressionJAMA Neurology2014402
26Parkinson Disease SubtypesJAMA Neurology2014397
27Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain InjuryJAMA Neurology2019390
28Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson DiseaseJAMA Neurology2016385
29Autoimmune Glial Fibrillary Acidic Protein AstrocytopathyJAMA Neurology2016383
30A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy BodiesJAMA Neurology2013374
31Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging BrainsJAMA Neurology2017367
32Midlife Hypertension and 20-Year Cognitive ChangeJAMA Neurology2014358
33Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple SclerosisJAMA Neurology2020357
34Frequency and Characteristics of Isolated Psychiatric Episodes in Anti–N-Methyl-d-Aspartate Receptor EncephalitisJAMA Neurology2013354
35Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease ProgressionJAMA Neurology2016354
36Dementia Risk After Traumatic Brain Injury vs Nonbrain TraumaJAMA Neurology2014352
37Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain InjuryJAMA Neurology2016348
38Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable TherapiesJAMA Neurology2020342
39Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic FindingsJAMA Neurology2016337
40The Idiopathic Intracranial Hypertension Treatment TrialJAMA Neurology2014336
41Blood Biomarkers for Brain Injury in Concussed Professional Ice Hockey PlayersJAMA Neurology2014336
42Congenital Zika Virus InfectionJAMA Neurology2016334
43Sleep and Circadian Rhythm Regulation in Early Parkinson DiseaseJAMA Neurology2014333
44Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis CohortJAMA Neurology2015328
45Effect of 1 Night of Total Sleep Deprivation on Cerebrospinal Fluid β-Amyloid 42 in Healthy Middle-Aged MenJAMA Neurology2014320
46Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson DiseaseJAMA Neurology2013318
47Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and AnosmiaJAMA Neurology2020315
48Neurologic and Radiographic Findings Associated With COVID-19 Infection in ChildrenJAMA Neurology2020314
49A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson DiseaseJAMA Neurology2014312
50Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal FluidJAMA Neurology2017312